CDH1 and central nervous system cancer: Dysregulation of E-cadherin expression has been observed in invasive glioma phenotypes, with decreased E-cadherin levels potentially reducing tumor migration and increased expression correlating with enhanced invasiveness—an observation that contrasts with the role of E-cadherin in epithelial tumors.22